Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ADMA Biologics Inc logo

ADMA Biologics Inc

Sector: Healthcare   

Industry: Biotechnology

5.38
 
USD
  
-0.14
  
(-2.54%)
Optionable: Yes  Market Cap: 1,247 M  90-day average vol: 2,212,739

Previous close: 5.52  Open: 5.53  Bid: 5.36  Ask: 5.41
52 week range    
2.95   
   5.58
Peers   
NVAX / 
RGEN / 
Last updated: Thursday 29th February 2024
54
MarketXLS Rank
20
Value
92
Technical
52
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CVM

0 B-6.55.71

NVAX

7 B-6.394.8

RGEN

11 B94.4201.39
Financials

ADMA Income Statement

Annual
Mar-14Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles1 M844938.0844938.0715353.0715353.0715353.0
Basic EPS from continuing operations-0.88
Basic EPS total-1.17-0.88-0.51-0.33
Basic weighted shares outstanding9 M9 M10 M12 M23 M45 M54 M86 M140 M198 M
Cost of sales977030.0-4 M-4 M-6 M-29 M-42 M40 M61 M-80 M-119 M
Depreciation-247852.0-469821.0-400000.0-3 M-3 M-3 M-4 M-5 M-7 M
Depreciation unreconciled-48299.0-247852.0-469821.0-469576.01 M844938.0844938.0715353.0715353.0715353.0
DepreciationAndAmortization-48299.0-247852.0-469821.0-469576.01 M844938.0844938.0715353.0715353.0715353.0
Diluted EPS total-0.64-1.81-1.73-1.61-1.91-1.45-0.89-0.88-0.51-0.33
Diluted normalized net income/share-0.89-0.88
Diluted weighted shares outstanding9 M10 M12 M23 M45 M54 M86 M140 M198 M
GainOnSaleOfPPE207071.081697.0
GainOnSaleOfSecurity5220.0-74356.067860.0
GeneralAndAdministrativeExpense1 M5 M7 M8 M19 M23 M26 M-700000.0-1 M-2 M
Gross operating profit564640.02 M3 M4 M-6 M-25 M-10 M-19 M1 M35 M
ImpairmentOfCapitalAssets845389.0
Income before tax-6 M-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M
Income restructuring and M&A83 M53 M
Income taxes-551724.0-602391.0-1 M-17 M-104430.0-474229.0-416312.0-231467.0
Interest income1779.014217.037830.050317.057228.0195403.012 M288126.034532.044833.0
InterestExpenseNonOperating226885.01 M2 M2 M3 M6 M9 M12 M13 M19 M
InterestExpenseOperating-2 M-2 M-4 M-10 M-10 M-11 M-14 M
MarketingExpense-200000.0-600000.0-800000.0-1000000.0-1 M-1 M-2 M
MiscOtherSpecialCharges74356.0-719097.04496.0-1 M-127121.0-10 M863269.0-251575.0-7 M
Net income from total operations-6 M-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M
NetIncomeCommonStockholders-6 M-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M
NetIncomeContinuousOperations-6 M-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M
NetNonOperatingInterestIncomeExpense-225106.0-1 M-2 M-2 M-3 M-5 M3 M-12 M-13 M-19 M
Operating income-6 M-16 M-16 M-17 M-38 M-60 M-41 M-65 M-58 M-39 M
Operating income before depreciation (EBITDA)-6 M-16 M-15 M-18 M-39 M-60 M-45 M-68 M-63 M-51 M
OperatingExpense6 M-22 M-23 M-28 M-62 M-77 M31 M46 M-60 M-75 M
Other income net-5220.074356.0651237.0-4496.01 M127121.010 M-863269.0251575.07 M
Other special charges-3 M
OtherGandA1 M5 M7 M8 M19 M23 M26 M-700000.0-1 M-2 M
OtherOperatingExpenses802469.04 M5 M5 M7 M8 M2 M4 M12 M18 M
RentAndLandingFees1 M5 M7 M8 M19 M23 M-600000.0-700000.0
Research & development expense4 M10 M7 M8 M6 M4 M2 M6 M4 M4 M
ResearchExpense4 M10 M7 M8 M6 M4 M2 M6 M4 M4 M
RestructringAndMnAIncome83 M53 M
Revenue per share1 M844938.0844938.0715353.0715353.0715353.0
SalariesAndWages-18889.0-1 M-2 M-1 M-2 M-2 M-3 M-3 M-3 M-5 M
Selling Gen & administrative expense1 M5 M7 M8 M19 M23 M26 M35 M43 M52 M
SellingAndMarketingExpense-200000.0-600000.0-800000.0-1000000.035 M43 M52 M
SellingExpense35 M43 M52 M
Special income/charges-83 M-845389.03 M
Total Income available for interest expense (EBIT)-6 M-16 M-16 M-19 M-43 M-65 M-50 M-74 M-70 M-61 M
Total common shares outstanding9 M9 M11 M13 M45 M46 M86 M121 M196 M222 M
Total net income-6 M-17 M-18 M-20 M-44 M-66 M-48 M-76 M-72 M-66 M
Total ordinary shares226 M226 M226 M226 M226 M226 M226 M226 M226 M226 M
Total revenues2 M6 M7 M11 M23 M17 M29 M42 M81 M154 M
TotalExpenses7 M-26 M-27 M-34 M-91 M-119 M71 M107 M-139 M-193 M
TotalRevenue2 M6 M7 M11 M23 M17 M29 M42 M81 M154 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University